• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中神经退行性变的可能机制。

Possible mechanisms of neurodegeneration in schizophrenia.

作者信息

Pérez-Neri Iván, Ramírez-Bermúdez Jesús, Montes Sergio, Ríos Camilo

机构信息

Department of Neurochemistry, National Institute of Neurology and Neurosurgery, Insurgentes Sur 3877 Col. La Fama. Tlalpan, 14269, Mexico City, Mexico.

出版信息

Neurochem Res. 2006 Oct;31(10):1279-94. doi: 10.1007/s11064-006-9162-3. Epub 2006 Sep 28.

DOI:10.1007/s11064-006-9162-3
PMID:17006758
Abstract

Brain morphological alterations in schizophrenic patients have led to the neurodevelopmental hypothesis of schizophrenia. On the other hand, a progressive neurodegenerative process has also been suggested and some follow-up studies have shown progressive morphological changes in schizophrenic patients. Several neurotransmitter systems have been suggested to be involved in this disorder and some of them could lead to neuronal death under certain conditions. This review discusses some of the biochemical pathways that could lead to neurodegeneration in schizophrenia showing that neuronal death may have a role in the etiology or natural course of this disorder.

摘要

精神分裂症患者的脑形态学改变引发了精神分裂症的神经发育假说。另一方面,也有人提出存在进行性神经退行性变过程,一些随访研究显示精神分裂症患者存在进行性形态学变化。有几种神经递质系统被认为与这种疾病有关,其中一些在某些情况下可能导致神经元死亡。本综述讨论了一些可能导致精神分裂症神经退行性变的生化途径,表明神经元死亡可能在这种疾病的病因或自然病程中起作用。

相似文献

1
Possible mechanisms of neurodegeneration in schizophrenia.精神分裂症中神经退行性变的可能机制。
Neurochem Res. 2006 Oct;31(10):1279-94. doi: 10.1007/s11064-006-9162-3. Epub 2006 Sep 28.
2
Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.精神分裂症发病机制及临床病程中的病理生理机制
J Clin Psychiatry. 1999;60 Suppl 12:9-12.
3
Cognitive function in schizophrenic patients.精神分裂症患者的认知功能
J Clin Psychiatry. 1996;57 Suppl 11:31-9.
4
Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.精神分裂症中一元胺、谷氨酸和γ-氨基丁酸之间的相互作用:新证据
Annu Rev Pharmacol Toxicol. 2001;41:237-60. doi: 10.1146/annurev.pharmtox.41.1.237.
5
Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia.α7 型烟碱型乙酰胆碱能神经调质可能调和精神分裂症的多种神经递质假说。
Med Hypotheses. 2012 May;78(5):594-600. doi: 10.1016/j.mehy.2012.01.035. Epub 2012 Feb 13.
6
[Pathophysiology of schizophrenia and its impact on pharmacotherapy].精神分裂症的病理生理学及其对药物治疗的影响
Fortschr Neurol Psychiatr. 2005 Nov;73 Suppl 1:S32-7. doi: 10.1055/s-2005-915546.
7
Is active psychosis neurotoxic?活动性精神病具有神经毒性吗?
Schizophr Bull. 2006 Oct;32(4):609-13. doi: 10.1093/schbul/sbl032. Epub 2006 Aug 16.
8
Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.靶向离子型谷氨酸受体治疗精神分裂症的最新进展。
Curr Pharm Biotechnol. 2012 Jun;13(8):1535-42. doi: 10.2174/138920112800784899.
9
The neurobiology of schizophrenia.精神分裂症的神经生物学
Pharmacotherapy. 1996 Nov-Dec;16(6 Pt 2):143S-147S; discussion 166S-168S.
10
Neurodegeneration in schizophrenia: evidence from in vivo neuroimaging studies.精神分裂症中的神经退行性变:来自活体神经影像学研究的证据。
ScientificWorldJournal. 2007 Feb 2;7:135-43. doi: 10.1100/tsw.2007.47.

引用本文的文献

1
Brain Structural Alterations Underlying Mood-Related Deficits in Schizophrenia.精神分裂症中与情绪相关缺陷背后的脑结构改变。
Biomedicines. 2025 Mar 18;13(3):736. doi: 10.3390/biomedicines13030736.
2
Small world properties of schizophrenia and OCD patients derived from fNIRS based functional brain network connectivity metrics.基于功能近红外光谱的脑功能网络连接度指标得出的精神分裂症和强迫症患者的小世界属性。
Sci Rep. 2024 Oct 16;14(1):24314. doi: 10.1038/s41598-024-72199-0.
3
Raphe Nuclei Echogenicity and Diameter of Third Ventricle in Schizophrenia Measured by Transcranial Sonography.

本文引用的文献

1
Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity.氯胺酮对运动、认知功能和中枢神经元活动影响的剂量反应特征。
Brain Res Bull. 2006 Apr 14;69(3):338-45. doi: 10.1016/j.brainresbull.2006.01.010. Epub 2006 Feb 10.
2
Protein kinase A regulates calcium permeability of NMDA receptors.蛋白激酶A调节N-甲基-D-天冬氨酸受体的钙通透性。
Nat Neurosci. 2006 Apr;9(4):501-10. doi: 10.1038/nn1664. Epub 2006 Mar 12.
3
Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke.
经颅超声测量精神分裂症中缝核回声及第三脑室直径
Basic Clin Neurosci. 2023 Jul-Aug;14(4):463-469. doi: 10.32598/bcn.2021.1604.1. Epub 2023 Jul 1.
4
Effects of Current Psychotropic Drugs on Inflammation and Immune System.当前精神类药物对炎症和免疫系统的影响。
Adv Exp Med Biol. 2023;1411:407-434. doi: 10.1007/978-981-19-7376-5_18.
5
The instrumental role of operant paradigms in translational psychiatric research: Insights from a maternal immune activation model of schizophrenia risk.操作性条件反射范式在精神医学转化研究中的工具性作用:精神分裂症风险的母体免疫激活模型的启示。
J Exp Anal Behav. 2022 May;117(3):560-575. doi: 10.1002/jeab.753. Epub 2022 Mar 23.
6
Validation of Induced Microglia-Like Cells (iMG Cells) for Future Studies of Brain Diseases.诱导性小胶质细胞样细胞(iMG细胞)用于未来脑部疾病研究的验证
Front Cell Neurosci. 2021 Apr 9;15:629279. doi: 10.3389/fncel.2021.629279. eCollection 2021.
7
Altered Causal Coupling Pathways within the Central-Autonomic-Network in Patients Suffering from Schizophrenia.精神分裂症患者中枢自主神经网络内因果耦合通路的改变
Entropy (Basel). 2019 Jul 26;21(8):733. doi: 10.3390/e21080733.
8
Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing.精神分裂症的抗炎策略:治疗应用及药物重新利用的证据综述
Clin Psychopharmacol Neurosci. 2020 Feb 29;18(1):10-24. doi: 10.9758/cpn.2020.18.1.10.
9
Diagnostic Accuracy of Brain-derived Neurotrophic Factor and Nitric Oxide in Patients with Schizophrenia: A pilot study.脑源性神经营养因子和一氧化氮对精神分裂症患者的诊断准确性:一项初步研究。
J Med Biochem. 2016 Jan;35(1):7-16. doi: 10.1515/jomb-2015-0010. Epub 2015 Dec 30.
10
The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.叶酸缺乏或补充饮食在雌性大鼠妊娠期及其成年后代中对精神分裂症动物模型的影响评估。
Mol Neurobiol. 2018 Mar;55(3):2301-2319. doi: 10.1007/s12035-017-0493-7. Epub 2017 Mar 24.
实验性中风后不同一氧化氮供体对大鼠的脑血管保护作用。
Nitric Oxide. 2006 Sep;15(2):114-24. doi: 10.1016/j.niox.2006.01.008. Epub 2006 Mar 9.
4
Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder.患有精神分裂症或反社会人格障碍男性的大脑结构体积异常。
Behav Brain Res. 2006 May 15;169(2):239-47. doi: 10.1016/j.bbr.2006.01.009. Epub 2006 Feb 8.
5
Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?抗精神病药物相关的大脑神经元变化:对精神分裂症的长期预后而言是毒性作用、治疗作用还是无关因素?
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):174-89. doi: 10.1016/j.pnpbp.2005.08.019. Epub 2005 Dec 22.
6
The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats.长期给予喹硫平对大鼠苯环利定诱导的参考记忆损伤及后扣带回皮质中Bcl-XL/Bax比值降低的影响。
Behav Brain Res. 2006 Apr 3;168(2):236-42. doi: 10.1016/j.bbr.2005.11.014. Epub 2005 Dec 19.
7
Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death.谷氨酸转运体在缺血期间谷氨酸清除和释放中的作用及其与神经元死亡的关系。
Arch Med Res. 2006 Jan;37(1):11-8. doi: 10.1016/j.arcmed.2005.05.014.
8
A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.一种与精神分裂症相关的感觉运动缺陷将含α3的GABAA受体与多巴胺功能亢进联系起来。
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17154-9. doi: 10.1073/pnas.0508752102. Epub 2005 Nov 11.
9
Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport.精神分裂症的谷氨酸能假说:Na+/K+依赖性谷氨酸转运的参与
J Biomed Sci. 2005 Dec;12(6):975-84. doi: 10.1007/s11373-005-9015-0. Epub 2005 Oct 14.
10
Failure to confirm allelic association between markers at the CAPON gene locus and schizophrenia in a British sample.在一个英国样本中未能证实CAPON基因座标记与精神分裂症之间的等位基因关联。
Biol Psychiatry. 2006 Jan 15;59(2):195-7. doi: 10.1016/j.biopsych.2005.08.015. Epub 2005 Oct 3.